期刊文献+

儿童呼吸科临床药师参与药物咨询223例回顾性分析 被引量:2

Retrospectively analysis of 223 cases medicine consultation of clinical pharmacist in pediatric respiratory department
原文传递
导出
摘要 目的总结临床药师在呼吸科病房解答的部分药物咨询问题,为日后临床工作提供参考。方法对2018年1月至12月间223例有临床药师参与、于我院呼吸科就诊并住院的患者用药相关问题进行回顾性分析。结果 223例问题来源按咨询问题者职称分布可分为主任医师15例(6.73%)、副主任医师26例(11.66%)、主治医师38例(17.04%)、住院医师124例(55.61%)、护士20例(8.97%)。咨询问题内容按咨询药物种类分为抗菌药物107例(47.98%)、抗病毒药物14例(6.28%)、止咳平喘化痰药14例(6.28%)、保肝药10例(4.48%)、抗过敏药9例(4.04%)、抗凝药物7例(3.14%)、利胆药6例(2.69%)、其他类别56例(25.11%)。咨询问题内容按咨询问题类别分为用法、用量类101例(45.29%)、药物选择类19例(8.15%)、药物不良反应类15例(6.73%)、其他类别占比88例(39.46%)。结论儿童呼吸科用药尤其是抗菌药物的合理用药是临床工作的重点。 Objective To summarize part of the drug consultation questions answered by clinical pharmacists in the respiratory ward,so as to provide reference for future clinical work.Methods A retrospective analysis was made on 223 patients with clinical pharmacists’ participation and hospitalized in the respiratory department of our hospital from January to December 2018.Results According to the professional titles of consultants,the sources of consultation questions can be divided into 15 chief physicians(6.73%),26 deputy chief physicians(11.66%),38 attending physicians(17.04%),124 residents(55.61%),20 nurses(8.97%).According to the types of consulting drugs,consulting questions were divided into 107 cases(47.98%) of antimicrobial agents,14 cases (6.28%) of antiviral drugs,14 cases(6.28%) of cough and asthma expectorant drugs,10 cases(4.48%) of protect liver medicine,9 cases(4.04%) of antiallergic,7 cases(3.14%) of anticoagulant drugs,6 cases(2.69%) of cholagogue,and 56 cases of other types(25.11%).According to the types of consultation questions,101 cases(45.29%) were classified into usage and dosage categories,19 cases(8.15%) were classified into drug selection categories,15 cases(6.73%) were classified into adverse drug reactions categories,and 88 cases(39.46%)were classified into other categories.Conclusion Rational use of children’s respiratory drugs,especially antibiotics,is the key point of clinical work.
作者 刘小会 刘军 姚瑶 赵志鹏 王晓玲 徐保平 LIU Xiao-Hui;LIU Jun;YAO-yao;ZHAO Zhi-peng;WANG Xiao-ling;XU Bao-ping(Pharmacy Department,Beijing Children's Hospital,Children's Hospital,Capital University of Medical Sciences,National Center for Children's health,Beijing 100045,China;Department of Respiratory,China National Clinical Research Center for Respiratory Diseases,Beijing Children's Hospital,National Center for Children's Health,Beijing 100045,China)
出处 《世界临床药物》 CAS 2020年第1期69-73,共5页 World Clinical Drug
基金 科技部国家科技重大专项课题:儿童常见病示范性新药临床评价技术平台建设(2017ZX0930402900)。
关键词 临床药师 药物咨询 呼吸科 clinical pharmacist medicine consultation respiratory department
  • 相关文献

参考文献12

二级参考文献45

  • 1梁秀华.不同体位对长效青霉素一次性注射成功率的影响[J].医学理论与实践,2004,17(11):1346-1346. 被引量:13
  • 2FALAGAS ME,SIEMPOS II, VARDAKAS KZ. Linezolid versus glycopeptides or beta-lactam for treatment of Gram-positive bacte- rial infections: mata-analysis of randomized controlled trials[J]. Lancet Infect Dis ,2008,8 (1) :53 -66. 被引量:1
  • 3RUBINSTEIN E, ISTURIZ R, HAROLD C,et al. Worldwide as- sessment of linezolid's clinical safety and tolerability:Comparator- controlled phase m studies [ J ]. Antimicrob Agents Chemother, 2003,47(6) :1824 - 1831. 被引量:1
  • 4BERNSTEIN WB, TROTTA RF, RECTOR JT, et al. Mecha- nisms for linezolid-induced anemia and thrombocytopenia [ J ]. Ann Pharmacother, 2003, 37 (4): 517- 520. 被引量:1
  • 5GEORGE JN, ASTER RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management [ J ]. Hematology, 2009,2009(1 ) : 153 - 158. 被引量:1
  • 6GARAZZINO S, DE ROSA FG, BARGIACCHI O, et al. Haema- tological safety of long-term therapy with linezolid[ J]. lnt J Anti- microb Agents, 2007,29 (4) :480 - 483. 被引量:1
  • 7DIEKEMA DI, JONES RN. Oxazolidinones: a review[J]. Drags, 2000, 59(1) :7 -16. 被引量:1
  • 8TAKAHASHI Y, TAKESUE Y, NAKAJIMA K, et al. Risk fac- tors associated with the development of thrombocytopeniain pa- tients who received linezolid therapy [ J ]. J Infect Chemother, 2011,17(3) :382 -387. 被引量:1
  • 9TSUJI Y, HIRAKI Y, MATSUMOTO K,et al. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction[ J ]. J Infect Chemother,2011,17 (1) :70 -75. 被引量:1
  • 10LIN YH,WU VC,TSAI IJ, et al. High frequency of linezolid-as- sociated thrombocytopenia among patients with renal insufficiency [ J ]. Int J Antimicrob Agents,2006,28 (4) : 345 - 351. 被引量:1

共引文献82

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部